Carbohydrates as scaffolds in drug discovery

ChemMedChem
Wim MeutermansBernd Becker

Abstract

Drug discovery has long suffered from the difficulty of having to place pharmacophoric groups in just the right spatial arrangement to elicit the desired biological response. Although some molecule classes have been discovered that seem to be privileged structures for at least some drug-receptor interactions, there remains the challenge to design and synthesize molecules with high specific affinity to pharmacologically important targets. With their high density of stereochemical information and their relative rigidity, carbohydrates provide excellent platforms upon which to display a number of substituents in a sterically defined way, hence offering the opportunity to harness their unique features for the drug-discovery process. This review highlights the progress that has been made in the development of carbohydrate scaffolds for drug discovery.

References

Jan 1, 1997·Molecular Diversity·M J Sofia
Aug 28, 1999·Journal of Medicinal Chemistry·Michael J SofiaH R Axelrod
Apr 25, 2000·Accounts of Chemical Research·S WendebornS Berteina
Dec 2, 2000·The Journal of Organic Chemistry·Ralph HirschmannAmos B Smith
Feb 14, 2002·Chemical Reviews·Sibylle A W GrunerHorst Kessler
Apr 12, 2002·Current Medicinal Chemistry·Tushar K ChakrabortySarva Jayaprakash
Apr 23, 2002·Combinatorial Chemistry & High Throughput Screening·Karla D RandellPrabhat Arya
May 15, 2002·Journal of Combinatorial Chemistry·Elaine B KruegerArmen M Boldi
Jun 29, 2002·Cellular and Molecular Life Sciences : CMLS·K J Jensen, J Brask
Aug 16, 2002·Combinatorial Chemistry & High Throughput Screening·Tushar K ChakrabortySubhash Ghosh
Oct 4, 2002·Chemistry : a European Journal·Laura CipollaFrancesco Nicotra
Nov 16, 2002·Carbohydrate Research·Till OpatzHorst Kunz
Jul 3, 2003·Nature Reviews. Drug Discovery·Simon J Teague
Jul 23, 2003·Bioorganic & Medicinal Chemistry Letters·Hideki MoriyamaShin-Ichiro Nishimura
Jul 23, 2003·Bioorganic & Medicinal Chemistry Letters·Hideki MoriyamaShin-Ichiro Nishimura
Aug 9, 2003·Journal of Medicinal Chemistry·Stephen HanessianLucienne Juillerat-Jeanneret
Aug 21, 2003·Drug Discovery Today·Giang Thanh LeWim Meutermans
Nov 25, 2003·The Journal of Organic Chemistry·Mattie S M TimmerHerman S Overkleeft
Mar 9, 2004·Journal of Combinatorial Chemistry·Alison A EdwardsGeorge W J Fleet
Mar 10, 2004·Bioorganic & Medicinal Chemistry Letters·Takahiro TsukidaShin-Ichiro Nishimura
Apr 2, 2004·Journal of Medicinal Chemistry·Hideki MoriyamaShin-Ichiro Nishimura
Oct 8, 2005·The Journal of Organic Chemistry·Sebastien G Gouin, Paul V Murphy
Nov 22, 2005·Biochemical Pharmacology·Judy HallidayWim Meutermans
Jan 13, 2006·Bioorganic & Medicinal Chemistry Letters·Steven Van HoofJohan Van der Eycken
Jan 28, 2006·Bioorganic & Medicinal Chemistry·Giovanni CerviFrancesco Nicotra
Oct 2, 1998·Angewandte Chemie·Tobias WunbergHorst Kunz

Citations

Aug 20, 2011·Journal of Medicinal Chemistry·Jason C MorrisSally-Ann Poulsen
Mar 31, 2009·Journal of Medicinal Chemistry·Noha ElmouelhiKevin J Yarema
Feb 24, 2011·The Journal of Organic Chemistry·Baudouin GerardLisa A Marcaurelle
Sep 30, 2008·Natural Product Reports·Kristina GrabowskiGisbert Schneider
May 4, 2013·Tissue Engineering. Part a·Jeannine M CoburnJennifer H Elisseeff
Aug 14, 2009·Glycobiology·Jian DuKevin J Yarema
Mar 24, 2011·Future Medicinal Chemistry·Laura CipollaFrancesco Nicotra
Apr 24, 2014·International Journal of Molecular Sciences·Zining CuiYoshihiro Nishida
Jun 28, 2014·Carbohydrate Research·Chao-Ying ChengGuo-Rong Chen
Oct 13, 2011·Organic Letters·Jian ZhouPaul V Murphy
Aug 1, 2010·Expert Opinion on Drug Discovery·Laura CipollaNasrin Shaikh
Dec 4, 2015·Organic & Biomolecular Chemistry·E LenciAndrea Trabocchi
Aug 3, 2010·Tetrahedron Letters·Kaori Sakurai, Daniel Kahne
Apr 2, 2010·Bioorganic & Medicinal Chemistry Letters·Hefang ShiRenxiao Wang
Jun 9, 2009·Chemistry : a European Journal·Claudia LalliAntonio Guarna
Apr 18, 2008·ChemMedChem·Vincent ChagnaultPaul V Murphy
Jul 5, 2012·Archiv der Pharmazie·Yousheng GuanAndreas Link
Jul 4, 2012·Chemistry, an Asian Journal·Ramu EnugalaM Manuel B Marques
Sep 17, 2011·Chemical Biology & Drug Design·Yuxin LiZhengming Li
Mar 22, 2016·Carbohydrate Research·Tobias-Elias GloeThisbe K Lindhorst
Jul 24, 2010·Biotechnology and Applied Biochemistry·Tony Merry, Sviatlana Astrautsova
Apr 20, 2010·Carbohydrate Research·Ming ZhongZhong-Jun Li
Mar 28, 2013·European Journal of Medicinal Chemistry·Qing-Chao LiuYing-Xia Li
Dec 19, 2012·Bioorganic & Medicinal Chemistry Letters·Cindy J CarrouxSally-Ann Poulsen
May 29, 2012·European Journal of Medicinal Chemistry·Yanli CuiYongping Yu
Apr 2, 2014·Antimicrobial Agents and Chemotherapy·Vivek KashyapArun K Shaw
Mar 5, 2019·Current Medicinal Chemistry·Kartikey Singh, Rama Pati Tripathi
Dec 10, 2020·Journal of Cheminformatics·Jonas SchaubMaria Sorokina
Dec 18, 2020·Organic & Biomolecular Chemistry·Victoria Dimakos, Mark S Taylor
Dec 5, 2018·European Journal of Medicinal Chemistry·Arvind NegiPaul V Murphy

Related Concepts

Carbohydrate Linkage
Sugars
Pharmaceutical Preparations
Drug Modeling

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Systemic Juvenile Idiopathic Arthritis

Systemic juvenile idiopathic arthritis is a rare rheumatic disease that affects children. Symptoms include joint pain, but also fevers and skin rashes. Here is the latest on this disease.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Pontocerebellar Hypoplasia

Pontocerebellar hypoplasias are a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments. Here is the latest research on pontocerebellar hypoplasia.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.

Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease that occurs in individuals that suffer repetitive brain trauma. Discover the latest research on traumatic encephalopathy here.